Form D · Biotechnology
BLOOD CELL STORAGE INC
Seattle, WA · CIK 0001126927
Offering snapshot reported May 18, 2012 · SEC filing
- Reported sold
- $2.38M Offering amount: $6M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jan 12, 2012 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$50,000 → $2,375,000
- Reported investors2 → 21
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 18, 2012 | Amendment | $2,375,000 | $2,325,000vs Jan 13, 2012 | 21 | SEC filing |
| Jan 13, 2012 | Initial | $50,000 | No comparison | 2 | SEC filing |
| Aug 18, 2010 | Initial | $0 | No comparison | 4 | SEC filing |
| Mar 4, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 16, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 2, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-171815
In addition to Secured Convertible Promissory Notes with an aggregate principal amount of up to $4,000,000, the Company is also issuing warrants to purchase up to 8,000,000 shares of common stock with a maximum aggregate value of $2,000,000.
Source: Form D, filed May 18, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Russell Aldrich | Director, Executive |
| Justin Foley | Director |
| Donald Gher | Director |
| Geoff Holmes | Director |
| Harvey Hoyt | Director |
| Kenneth Wang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
454 North 34 Th Street Lower Level
Seattle, WA, 98103
Seattle, WA, 98103